CONTROL OF THE DOSAGE OF ANTIPNEUMOCOCCAL SERUM IN THE TREATMENT OF PNEUMONIA
Authors: P. C.
Journal: Annals of Internal Medicine (1940)

Editorial1 May 1940CONTROL OF THE DOSAGE OF ANTIPNEUMOCOCCAL SERUM IN THE TREATMENT OF PNEUMONIAP. C.P. C.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-13-11-2178 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptSince effective antipneumococcal sera first became available for the treatment of acute lobar pneumonia the need of some precise method for determining the quantity of serum required has been evident. Attempts have been made to estimate this by considering such factors as the day of the disease on which treatment is started, the extent of the lung tissue affected, the presence or absence of bacteremia and the apparent degree of intoxication, as well as the clinical response to treatment. Although these points are of considerable assistance in the absence of more precise standards, experience soon showed that they are not...1 SABIN AB: The microscopic agglutination test in pneumonia; its application to rapid typing and control of serum therapy, Jr. Infect. Dis., 1930, xlvi, 469. CrossrefGoogle Scholar2 BULLOVA JG: The management of the pneumonias, 1937, Oxford University Press, New York. Google Scholar3 BULLOVASHARFF JGJ: Quantitative capsule swelling tests in blood serum of pneumonia patients, Jr. Infect. Dis., 1937, lxi, 55. CrossrefGoogle Scholar4 TILLETFRANCIS WST: Cutaneous reactions to the polysaccharides and proteins of pneumococcus in lobar pneumonia, Jr. Exper. Med., 1929, i, 687. CrossrefGoogle Scholar5 FRANCIS T: The value of the skin test with type specific capsular polysaccharide in the serum treatment of type I pneumococcus pneumonia, Jr. Exper. Med., 1933, lvii, 617. CrossrefGoogle Scholar6 MACLEODHOAGLANDBENSON CMCLPB: The use of the skin test with the type specific polysaccharides in the control of the serum dosage in pneumococcal pneumonia, Jr. Clin. Invest., 1938, xvii, 739. CrossrefGoogle Scholar7 FINLAND M: Adequate dosage in the specific serum treatment of pneumococcus Type I pneumonia, Am. Jr. Med. Sci., 1936, cxlix, 849. Google Scholar8 WOOD WB: The control of the dosage of antiserum in the treatment of pneumococcal pneumonia. I. A study of the mechanism of the skin reaction to type specific polysaccharide, Jr. Clin. Invest., 1940, xix, 95. CrossrefGoogle Scholar IBID.: II. The clinical application of the Francis skin test, Jr. Clin. Invest., 1940, xix, 105. Google Scholar9 LONGWOOD PHWB: Observations upon the experimental and clinical use of sulfapyridine. II. The treatment of pneumococcal pneumonia with sulfapyridine, ANN. INT. MED, 1939, xiii, 487. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 May 1940Volume 13, Issue 11Page: 2178-2180KeywordsBacteremiaIntoxicationLungsPneumoniaRespiratory system procedures ePublished: 1 December 2008 Issue Published: 1 May 1940 PDF downloadLoading ...